RSS | Login | Register

ENDAL CD

Compare to Similar Drugs | Add to Clipboard | View Clipboard | Print | Email

Close [X]

Compare ENDAL CD to:

Generic Name for ENDAL CD

Codeine phosphate 7.5mg, phenylephrine HCl 7.5mg, diphenhydramine HCl 12.5mg; per 5 mL; sugar- , alcohol-, and dye-free; liq; cherry flavor.

Legal Classification:

Pharmacological Class for ENDAL CD

Antitussive + sympathomimetic + antihistamine.

Manufacturer of ENDAL CD

Tiber Laboratories

Indications for ENDAL CD

Cough, rhinorrhea, nasal congestion.

Adult dose for ENDAL CD

10mL every 4 hours; max 40mL/24hrs.

Children's dosing for ENDAL CD

<6yrs: not recommended. 6–12yrs: 5mL every 4 hours; max 20mL/24hrs.

Contraindications for ENDAL CD

Asthma. Lower respiratory disorders. Severe hypertension. Coronary artery disease. Narrow-angle glaucoma. Urinary retention. Peptic ulcer. Nursing mothers. Neonates. During or within 14 days of MAOIs.

Warnings/Precautions for ENDAL CD

Hypertension. Heart disease. Diabetes. Increased intraocular pressure. Thyroid disease. Severe hepatic or renal impairment. GI or GU obstruction. Head injury. Increased intracranial pressure. Acute abdomen. Post-op. Pulmonary disease. Drug abusers. Elderly. Debilitated. Labor & delivery. Pregnancy (Cat.C).

Interactions for ENDAL CD

See Contraindications. Hypertensive crisis with MAOIs. Avoid concomitant other diphenhydramine products (including topicals). Potentiation with alcohol, CNS depressants, MAOIs, tricyclic antidepressants, anticholinergics. β-blockers may increase pressor effects of sympathomimetics. Antihypertensives antagonized.

Adverse Reactions for ENDAL CD

CNS or respiratory depression, anticholinergic effects, tachycardia, palpitations, nervousness, dizziness, GI upset, insomnia, excitability (esp. in children).

How is ENDAL CD supplied?

Liq—16oz

Related Disease:

Congestion, nasal~antihistamine/decongestants

Cough

McNeil Consumer Healthcare product supply update

June 25, 2010

McNeil Consumer Healthcare announced that it does not anticipate having sources of supply for most of the products that were produced at its Fort Washington, Pennsylvania manufacturing facility before the end of 2010.

Vicks Sinex VapoSpray 4-Hour Decongestant Nasal Spray recalled

June 24, 2010

Procter & Gamble announced a voluntary nationwide recall of Vicks Sinex VapoSpray 4-Hour Decongestant Nasal Spray (oxymetazoline HCl).

Four PediaCare products recalled

June 01, 2010

The FDA and Blacksmith Brands notified healthcare professionals and consumers of a nationwide voluntary recall of all lots of four PediaCare children's products.

FDA launches "Bad Ad Program" to detect misleading drug ads

May 11, 2010

The FDA's Division of Drug Marketing, Advertising, and Communications (DDMAC) has launched the Bad Ad Program, designed to educate healthcare providers about their role in ensuring that prescription drug advertising and promotion is truthful, and not misleading.

Children's and Infants' liquid Tylenol, Motrin, Zyrtec, and Benadryl recalled

May 03, 2010

The FDA and McNeil Consumer Healthcare have notified healthcare professionals of a voluntary recall of certain over-the-counter (OTC) Children's and Infant's liquid Tylenol, Motrin, Zyrtec, and Benadryl products.